DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The "Live Cell Imaging Market - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Live Cell Imaging Market Size is Projected to Reach USD 2.8 Billion by 2025 from USD 1.8 Billion in 2020, at a CAGR of 8.8% during the Forecast Period.
Live cell imaging is an important analytical tool used to study living cells. Imaging systems such as microscopes and high-content screening systems are used in live cell imaging. These techniques are an integral part of a wide range of applications, such as cell biology, neurobiology, pharmacology, developmental biology, and drug discovery. Unlike other techniques that provide details on the current state of cells, live cell imaging helps investigate the dynamic processes in living cells.
The market for live cell imaging is driven primarily by the factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, growth in research funding, and rising government funding in regenerative medicine research. However, high cost of high-content screening systems will hinder the overall adoption of live cell imaging systems and thereby restrain market growth in the coming years.
Key Topics Covered:
1 Introduction
2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
2.5 COVID-19 Health Assessment
2.6 COVID-19 Economic Assessment
2.7 Assessment of the Impact of COVID-19 on the Economic Scenario
2.8 Assessment of the Impact of COVID-19 on the Economic Scenario of the Live Cell Imaging Market
3 Executive Summary
4 Premium Insights
4.1 Live Cell Imaging Market Overview
4.2 APAC: Live Cell Imaging Market, by Application (2019)
4.3 Live Cell Imaging Market: Geographic Growth Opportunities
4.4 Regional Mix: Live Cell Imaging Market
4.5 Live Cell Imaging Market: Developed Vs. Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Adoption of High-Content Screening Techniques in Drug Discovery
5.2.1.2 Rising Incidence of Cancer
5.2.1.3 Growing Availability of Research Funds
5.2.1.4 Rising Government Funding in Regenerative Medicine Research
5.2.2 Restraints
5.2.2.1 High Cost of High-Content Screening Systems
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Applications of Hcs in Personalized Medicine
5.2.4 Challenges
5.2.4.1 Maintaining Cell Viability and the Cellular Environment in Cell Cultures
5.2.4.2 Dearth of Skilled Professionals
5.3 COVID-19 Impact on the Live Cell Imaging Market
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Rising Focus of Market Players on Advanced Product Launches
6.2.2 Growing Adoption of Label-Free Technologies
6.3 Supply Chain Analysis
6.4 Value Chain Analysis
7 Live Cell Imaging Market, by Product & Service
7.1 Introduction
7.2 Impact of COVID-19 on the Live Cell Imaging Product & Service Market
7.3 Instruments
7.3.1 Microscopes
7.3.1.1 Broad Applications and Emerging Technologies Have Resulted in the Growing Demand for Microscopes
7.3.2 Standalone Systems
7.3.2.1 Standalone Systems Provide In-Depth Image Analysis of Live Cells at a Faster Rate-A Key Factor Driving Market Growth
7.3.3 Cell Analyzers
7.3.3.1 Players Offer a Wide Range of Cell Analyzers to Satisfy End-User Demands
7.3.4 Accessories
7.3.4.1 Accessories Find Wide Use in Live Cell Image Analysis
7.4 Consumables
7.4.1 Reagents
7.4.1.1 Reagents Have Widespread Usage in Life Sciences due to Their Application in Various Research Activities
7.4.2 Assay Kits
7.4.2.1 Repeat Purchase of Assay Kits-A Key Driver for Market Growth
7.4.3 Media
7.4.3.1 Development of New and Advanced Technologies Has Resulted in an Increased Demand for High-Quality Media in Biomedical Research and Processing
7.4.4 Other Consumables
7.5 Software
7.5.1 Technological Advancements in Image Acquisition-A Key Driver for Market Growth
7.6 Services
7.6.1 Availability of a Wide Range of Services and Growing Number of Initiatives by Key Players to Drive the Services Market
8 Live Cell Imaging Market, by Application
8.1 Introduction
8.2 Impact of COVID-19 on the Live Cell Imaging Applications Market
8.3 Cell Biology
8.3.1 Increasing Prevalence of Cancer to Drive Growth in the Cell Biology Application Segment
8.4 Stem Cells
8.4.1 Importance of Stem Cell Research Has Boosted Investments in this Area
8.5 Developmental Biology
8.5.1 Growing Research in Developmental Biology-A Key Driver for Market Growth
8.6 Drug Discovery
8.6.1 Use of Hcs Cell-Based Assays Has Grown in Drug Development Studies
9 Live Cell Imaging Market, by Technology
9.1 Introduction
9.2 Time-Lapse Microscopy
9.2.1 Growing Number of Cell-Based Research Activities Will Drive the Demand for Time-Lapse Microscopy
9.3 Fluorescence Resonance Energy Transfer (Fret)
9.3.1 Growing Advancements in Fluorescent Materials and Probes Will Increase the Adoption of Fret Technology
9.4 Fluorescence Recovery After Photobleaching (Frap)
9.4.1 Advancements in Confocal Microscopy Will Support the Market Growth for Frap
9.5 High-Content Screening (Hcs)
9.5.1 Increasing Drug Discovery Research to Drive the Growth of this Market
9.6 Other Technologies
10 Live Cell Imaging Market, by End-user
10.1 Introduction
Table 45 Live Cell Imaging Market, by End-user, 2018-2025 (USD Million)
10.2 Impact of COVID-19 on the Live Cell Imaging End-User Market
10.3 Pharmaceutical & Biotechnology Companies
10.3.1 Increasing R&D Activities and the Patent Cliff of Various Blockbuster Drugs to Increase the Demand for Live Cell Imaging Products Among Pharmaceutical & Biotechnology Companies
Table 46 Live Cell Imaging Market for Pharmaceutical & Biotechnology Companies, by Country, 2018-2025 (USD Million)
10.4 Academic & Research Institutes
10.4.1 Rising Focus of These End-users on Strengthening Their Own Drug Discovery Research Programs to Drive Market Growth
Table 47 Live Cell Imaging Market for Academic & Research Institutes, by Country, 2018-2025 (USD Million)
10.5 Contract Research Organizations
10.5.1 Growing Outsourcing of R&D Activities by Pharmaceutical Companies to Drive the Demand for Live Cell Imaging Systems Among Contract Research Organizations
Table 48 Live Cell Imaging Market for Contract Research Organizations, by Country, 2018-2025 (USD Million)
11 Live Cell Imaging Market, by Region
12 Competitive Landscape
12.1 Overview
12.2 Competitive Situation and Trends
12.2.1 Product Launches
12.2.2 Partnerships, Agreements, and Collaborations
12.2.3 Acquisitions
12.2.4 Expansions
13 Company Evaluation Matrix and Company Profiles
13.1 Company Evaluation Matrix Definition & Methodology
13.2 Competitive Leadership Mapping
13.2.1 Stars
13.2.2 Emerging Leaders
13.2.3 Pervasive Companies
13.2.4 Emerging Companies
13.3 Market Share Analysis
13.4 Company Profiles
13.4.1 Danaher Corporation
13.4.2 Carl Zeiss Ag
13.4.3 Nikon Corporation
13.4.4 Olympus Corporation
13.4.5 Perkinelmer Inc.
13.4.6 Sartorius Ag
13.4.7 Biotek Instruments, Inc.
13.4.8 Thermo Fisher Scientific
13.4.9 Etaluma, Inc.
13.4.10 Cytosmart Technologies
13.4.11 Nanoentek Inc.
13.4.12 GE Healthcare
13.4.13 Bruker Corporation
13.4.14 Becton, Dickinson and Company
13.4.15 Merck KGaA
13.4.16 Keyence Corporation
13.4.17 Logos Biosystems (Aligned Genetics Inc.)
13.4.18 Nanolive Sa
13.4.19 Sony Biotechnology Inc.
13.4.20 Phase Focus Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/inmr6
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-live-cell-imaging-market-report-2020-2025-market-size-is-projected-to-reach-usd-2-8-billion-by-2025-from-usd-1-8-billion-in-2020--301179091.html
SOURCE Research and Markets
